New Zealand markets closed

PODD Dec 2022 210.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.22000.0000 (0.00%)
As of 02:00PM EST. Market open.
Full screen
Previous close4.2200
Open4.2200
Bid0.0000
Ask1.5000
Strike210.00
Expiry date2022-12-16
Day's range4.2200 - 4.2200
Contract rangeN/A
Volume2
Open interest330
  • Motley Fool

    2 Best Medical Device Stocks for 2023

    Over the past five years, for instance, industry giants like Medtronic have lagged the broader markets from a capital appreciation standpoint due to headwinds emanating from legacy portfolios, while up-and-coming device makers such as the diabetes care company DexCom have yielded life-changing gains for shareholders. Armed with this background, I think the diabetes care specialist Insulet (NASDAQ: PODD) and the surgical device company Conmed (NYSE: CNMD) are poised to be medtech's two best performers in 2023. The diabetes care specialist Insulet has been a rare bright spot in the medtech stock space in 2022.

  • Simply Wall St.

    Insulet (NASDAQ:PODD) rallies 4.9% this week, taking five-year gains to 342%

    Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly...

  • Business Wire

    Insulet to Present at Upcoming Investor Conferences

    ACTON, Mass., November 22, 2022--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at two upcoming investor conferences: